EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab
Patients with X-linked lymphoproliferative disease 1 (XLP1) are exquisitely susceptible to Epstein-Barr virus (EBV), with the first EBV infection often resulting in rapid death. In a manner not previously described, a 5-year-old patient with XLP1 presented solely with behavioral aggression, with no...
Saved in:
| Main Authors: | Michelle M. Korah-Sedgwick, Luke A. Wall |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Immunology |
| Online Access: | http://dx.doi.org/10.1155/2018/3705376 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
by: Umaimainthan Palendira, et al.
Published: (2011-11-01) -
Case Report: Multiple peripheral nerve demyelinating lesions and cerebrovascular injury which resulted in extensive cerebral infarction in a XLP1 patient without EBV infection
by: Jiaxun Li, et al.
Published: (2025-05-01) -
Papilledema as the Sole Manifestation of Neuroborreliosis
by: Kaitlyn May, et al.
Published: (2021-01-01) -
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa
by: William Frank Mawalla, et al.
Published: (2025-05-01) -
Specific selection on XEG1 and XLP1 genes correlates with host range and adaptability in Phytophthora
by: Qi Zhang, et al.
Published: (2025-04-01)